MELANIE LOBEL: Open Payments
NPI 1013033273 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 8 payments from 5 companies in 2025. Trend: 2023 $69 · 2024 $683 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $270 |
| Teva Pharmaceuticals USA, Inc. | 2 | $244 |
| E.R. Squibb & Sons, L.L.C. | 2 | $144 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $106 |
Products named: INVEGA SUSTENNA, COBENFY, REXULTI, UZEDY, AUSTEDO XR, CAPLYTA.
Industry payments across SC — which companies pay providers there.
